302 related articles for article (PubMed ID: 21823902)
1. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
Ludwig S
Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
[TBL] [Abstract][Full Text] [Related]
2. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.
Ludwig S
J Antimicrob Chemother; 2009 Jul; 64(1):1-4. PubMed ID: 19420020
[TBL] [Abstract][Full Text] [Related]
3. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
5. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
6. [The substances active against influenza virus. Possibilities and prospects of application].
Kwiatek M; Kocik J; Bartoszcze M
Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
[TBL] [Abstract][Full Text] [Related]
7. Influenza, a One Health paradigm--novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential.
Ludwig S; Zell R; Schwemmle M; Herold S
Int J Med Microbiol; 2014 Oct; 304(7):894-901. PubMed ID: 25220817
[TBL] [Abstract][Full Text] [Related]
8. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
van de Wakker SI; Fischer MJE; Oosting RS
Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
[TBL] [Abstract][Full Text] [Related]
9. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
10. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
11. Host cellular signaling induced by influenza virus.
Dai X; Zhang L; Hong T
Sci China Life Sci; 2011 Jan; 54(1):68-74. PubMed ID: 21253874
[TBL] [Abstract][Full Text] [Related]
12. Use of siRNAs to prevent and treat influenza virus infection.
Ge Q; Eisen HN; Chen J
Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
[TBL] [Abstract][Full Text] [Related]
13. Influenza viruses: basic biology and potential drug targets.
Basler CF
Infect Disord Drug Targets; 2007 Dec; 7(4):282-93. PubMed ID: 18220960
[TBL] [Abstract][Full Text] [Related]
14. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Mol Biosyst; 2012 Apr; 8(4):1297-303. PubMed ID: 22307679
[TBL] [Abstract][Full Text] [Related]
15. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
Yan Q
Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
[TBL] [Abstract][Full Text] [Related]
16. Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.
Sgarbanti R; Nencioni L; Amatore D; Coluccio P; Fraternale A; Sale P; Mammola CL; Carpino G; Gaudio E; Magnani M; Ciriolo MR; Garaci E; Palamara AT
Antioxid Redox Signal; 2011 Aug; 15(3):593-606. PubMed ID: 21366409
[TBL] [Abstract][Full Text] [Related]
17. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
Lee SM; Yen HL
Antiviral Res; 2012 Dec; 96(3):391-404. PubMed ID: 23022351
[TBL] [Abstract][Full Text] [Related]
18. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy.
Ludwig S; Planz O
Biol Chem; 2008 Oct; 389(10):1307-12. PubMed ID: 18713017
[TBL] [Abstract][Full Text] [Related]
19. Development of cellular signaling pathway inhibitors as new antivirals against influenza.
Planz O
Antiviral Res; 2013 Jun; 98(3):457-68. PubMed ID: 23603495
[TBL] [Abstract][Full Text] [Related]
20. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
Mazur I; Wurzer WJ; Ehrhardt C; Pleschka S; Puthavathana P; Silberzahn T; Wolff T; Planz O; Ludwig S
Cell Microbiol; 2007 Jul; 9(7):1683-94. PubMed ID: 17324159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
